The Partido Popular government of Spain is looking to tighten the controls on pharmaceutical spending agreed by the former government and the drug industry association, Farmaindustria, last year (Marketletters passim).
Jose Manuel Romay Beccaria, the current Minister of Health and Rodrigo Rato, Minister for the Economy and Home Affairs, want to tighten controls and have expressed this to Farmaindustria in a number of recent meetings, reports the Spanish financial daily Cinco Dias. Enrique Castello, Undersecretary for Health, will be directing negotiations with drug companies in the coming weeks.
Currently, the ceiling for drug industry growth, agreed last year, is 7% over a three-year period. Farmaindustria is said not to have ruled out a renegotiation of the ceiling, although the association believes that the government should take a serious look at reducing pharmaceutical fraud, which is estimated to cost the industry between 50 billion pesetas ($390 million) and 100 billion pesetas a year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze